1 / 8

Cytotoxic Drugs Contract Manufacturing Market Analysis-2027

u201cCoherent Market Insights u201cCYTOTOXIC DRUGS CONTRACT MANUFACTURING MARKET u2013 GLOBAL TRENDS, ESTIMATES AND FORECASTS, 2020-2027u2033

SANJAYCMI
Download Presentation

Cytotoxic Drugs Contract Manufacturing Market Analysis-2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CYTOTOXIC DRUGS CONTRACT MANUFACTURING MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

  2. REPORT DESCRIPTION Cytotoxic Drugs Contract Manufacturing Market - Overview Global Cytotoxic Drugs Contract Manufacturing Market, by Production Scale (Industrial Scale, Pilot Scale, and Laboratory Scale), by Form (Liquid, and Solid), by Product Type (Oral and Intravenous), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 6,285.2 million in 2018, and is expected to exhibit a CAGR of 9.1% over the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights. Governments in emerging economies such as India are focusing on initiatives to increase domestic production. For instance, in August 2017, according to the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers of government of India proposed 'peak customs duty' and suggested setting up of bulk drug parks to increase domestic production. Furthermore, rapid growth in the pharmaceutical industry in the Asia Pacific region is expected to propel growth of cytotoxic drug contract manufacturing market in the Asia Pacific region during the forecast period. For instance, in September 2019, according to the Indian Brand Equity Foundation (IBEF), India pharmaceutical industry is expected to reach US$ 55 Bn by 2020. Increasing investment by the market players, in order to expand their service and product offerings is expected to boost growth of the cytotoxic drugs contract manufacturing market over the forecast period. Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/cytotoxic-drugs-contract-manufacturing-market-3175 © Coherent market Insights. All Rights Reserved

  3. REPORT DESCRIPTION Browse 38 Market Data Tables and 27 Figures spread through 193 Pages and in-depth TOC on ‘Cytotoxic Drugs Contract Manufacturing Market’- Global Forecast to 2027, by Production Scale (Industrial Scale, Pilot Scale, and Laboratory Scale), by Form (Liquid, and Solid), by Product Type (Oral and Intravenous), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) North America is expected to dominate cytotoxic drugs contract manufacturing market over the forecast period, owing to adoption of growth strategies such as product launches, investments, facility expansion by the market players in the region to expand their market presence. For instance, in 2016, Cambrex, a leading small molecule API contract manufacturer expanded its facility at Iowa, Charles City-based manufacturing site, adding 1,000- and 4,000 gallon glass-lined reactors in 7,500-square-foot plant. Moreover, market players are focused on collaboration and acquisition strategies to expand their market presence and enhance facility in the region, which is expected to drive growth of the market over the forecast period. For instance, in November 2017, CordenPharma International, a contract provider of both small-molecule APIs and drug products acquired a Hospira Boulder facility from Pfizer Inc., a 54,000-square-foot API manufacturing facility located in Colorado, U.S. to build its capabilities in high-potency manufacturing. According to the expansion strategy, the new facility specializes in development, scale-up, optimization, and production of highly potent and cytotoxic/cytostatic commercialization stage. APIs from development to Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3175 © Coherent market Insights. All Rights Reserved

  4. REPORT DESCRIPTION Key Takeaways of the Cytotoxic Drugs Contract Manufacturing Market: The global cytotoxic drugs contract manufacturing market is expected to exhibit a CAGR of 9.1% over the forecast period, owing to increasing adoption of collaboration and acquisition strategies by key players and rising trend of contact manufacturing. Contract development and manufacturing organizations (CDMOs) play a vital role in expediting development of innovative small molecule drug candidates, as these important development activities are often achieved through outsourcing partnerships with CDMOs Among form, liquid segment held dominant position in the cytotoxic drugs contract manufacturing market in 2018, owing to adoption of expansion strategies by the market players. For instance, in April 2018, STA Pharmaceutical, a subsidiary of WuXi AppTec, signed an investment agreement with the Government of Shanghai, to build a new research & development (R&D) center for APIs and intermediates located next to the company’s existing Jinshan drug-substance manufacturing site. Among product type, intravenous segment held dominant position in the cytotoxic drugs contract manufacturing market in 2018, owing to companies focusing on expansion of their manufacturing facilities for production of sterile injectable and API, in order to increase client base and cater to their demand. For instance, in March 2017, Piramal Pharma Solutions expanded manufacturing capabilities in Lexington, U.S. The new facility includes installation of a new high-speed vial filling line, expansion of the state-of-the art laboratories. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3175 © Coherent market Insights. All Rights Reserved

  5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

  6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

  7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

  8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved

More Related